Clinical spectrum and features of activated phosphoinositide 3-kinase Î´ syndrome: A large patient cohort study.
Coulter, Tanya I; Chandra, Anita; Bacon, Chris M; Babar, Judith; Curtis, James; Screaton, Nick; Goodlad, John R; Farmer, George; Steele, Cathal Laurence; Leahy, Timothy Ronan; Doffinger, Rainer; Baxendale, Helen; Bernatoniene, Jolanta; Edgar, J David M; Longhurst, Hilary J; Ehl, Stephan; Speckmann, Carsten; Grimbacher, Bodo; Sediva, Anna; Milota, Tomas; Faust, Saul N; Williams, Anthony P; Hayman, Grant; Kucuk, Zeynep Yesim; Hague, Rosie; French, Paul; Brooker, Richard; Forsyth, Peter; Herriot, Richard; Cancrini, Caterina; Palma, Paolo; Ariganello, Paola; Conlon, Niall; Feighery, Conleth; Gavin, Patrick J; Jones, Alison; Imai, Kohsuke; Ibrahim, Mohammad A A; Markelj, Gasper; Abinun, Mario; Rieux-Laucat, Frédéric; Latour, Sylvain; Pellier, Isabelle; Fischer, Alain; Touzot, Fabien; Casanova, Jean-Laurent; Durandy, Anne; Burns, Siobhan O; Savic, Sinisa; Kumararatne, D S.
J Allergy Clin Immunol
; 139(2): 597-606.e4, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27555459
SLAM family receptors and SAP adaptors in immunity.
Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders.
Post-transplant lymphoproliferative disease in liver transplant recipients.
Advances in the diagnosis and control of lymphomas.
II. Challenges in the management of post-transplant lymphoproliferative disorder.
Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: A literature review.
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
XIAP deficiency syndrome in humans.